Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Scientific Reports
|
February 23, 2022
Role of TRPC6 in kidney damage after acute ischemic kidney injury
Zhihuang Zheng, Dmitry Tsvetkov, Theda Ulrike Patricia Bartolomaeus, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2021
In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain
Sladjana Dukić-Stefanović, Thu Hang Lai, Magali Toussaint, et al.
Frontiers in Pharmacology
|
July 3, 2019
<i>In vitro</i> and <i>in vivo</i> Human Metabolism of (<i>S</i>)-[<sup>18</sup>F]Fluspidine - A Radioligand for Imaging σ<sub>1</sub> Receptors With Positron Emission Tomography (PET)
Friedrich-Alexander Ludwig, Steffen Fischer, Richard Houska, et al.
Journal of Medicinal Chemistry
|
April 18, 2018
N<sup>ε</sup>-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling
Robert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 30, 2024
Cellular Uptake of Phase-Separating Peptide Coacervates
Anastasia Shebanova, Quentin Moana Perrin, Kexin Zhu, et al.
Molecules (Basel, Switzerland)
|
May 20, 2020
Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging
Masoud Sadeghzadeh, Barbara Wenzel, Daniel Gündel, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
April 25, 2019
Development and radiosynthesis of the first <sup>18</sup> F-labeled inhibitor of monocarboxylate transporters (MCTs)
Masoud Sadeghzadeh, Rareş-Petru Moldovan, Steffen Fischer, et al.
Journal of Medicinal Chemistry
|
January 23, 2016
Development of a Novel Nonpeptidic (18)F-Labeled Radiotracer for in Vivo Imaging of Oxytocin Receptors with Positron Emission Tomography
Barbara Wenzel, Jan Mollitor, Winnie Deuther-Conrad, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2020
(+)-[<sup>18</sup>F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls
Solveig Tiepolt, Georg-Alexander Becker, Stephan Wilke, et al.
Blood
|
August 18, 2022
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML
Maike Roas, Binje Vick, Marc-André Kasper, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Scientific Reports
|
February 23, 2022
Role of TRPC6 in kidney damage after acute ischemic kidney injury
Zhihuang Zheng, Dmitry Tsvetkov, Theda Ulrike Patricia Bartolomaeus, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 13, 2021
In vitro and in vivo evaluation of fluorinated indanone derivatives as potential positron emission tomography agents for the imaging of monoamine oxidase B in the brain
Sladjana Dukić-Stefanović, Thu Hang Lai, Magali Toussaint, et al.
Frontiers in Pharmacology
|
July 3, 2019
<i>In vitro</i> and <i>in vivo</i> Human Metabolism of (<i>S</i>)-[<sup>18</sup>F]Fluspidine - A Radioligand for Imaging σ<sub>1</sub> Receptors With Positron Emission Tomography (PET)
Friedrich-Alexander Ludwig, Steffen Fischer, Richard Houska, et al.
Journal of Medicinal Chemistry
|
April 18, 2018
N<sup>ε</sup>-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic Profiling
Robert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 30, 2024
Cellular Uptake of Phase-Separating Peptide Coacervates
Anastasia Shebanova, Quentin Moana Perrin, Kexin Zhu, et al.
Molecules (Basel, Switzerland)
|
May 20, 2020
Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging
Masoud Sadeghzadeh, Barbara Wenzel, Daniel Gündel, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
April 25, 2019
Development and radiosynthesis of the first <sup>18</sup> F-labeled inhibitor of monocarboxylate transporters (MCTs)
Masoud Sadeghzadeh, Rareş-Petru Moldovan, Steffen Fischer, et al.
Journal of Medicinal Chemistry
|
January 23, 2016
Development of a Novel Nonpeptidic (18)F-Labeled Radiotracer for in Vivo Imaging of Oxytocin Receptors with Positron Emission Tomography
Barbara Wenzel, Jan Mollitor, Winnie Deuther-Conrad, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2020
(+)-[<sup>18</sup>F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls
Solveig Tiepolt, Georg-Alexander Becker, Stephan Wilke, et al.
Blood
|
August 18, 2022
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML
Maike Roas, Binje Vick, Marc-André Kasper, et al.
Page
of 8